CLS Holdings, (OTCQB: CLSH) Record January NET Revenue of $1.48 Million Beating Target


Miami, FL -- (February 9, 2021) –, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on CLS Holdings, Inc. (OTCQB: CLSH)


CLS Holdings, Inc. (OTCQB: CLSH) just announced that the results for its Nevada wholly owned subsidiaries for the month of January 2021 came in with net revenues of $1.48 Million and Gross Margin of 50.4%. The Company was targeting 50% gross margin.


CLS Holdings, Inc. (OTCQB: CLSH) by the numbers:

  • NET revenue for January 2021 was $1.48 million beating January 2020 by 28.5% and January 2019 by 100.4%


  • The dispensary processed an average of over 700 transactions per day.


  • Revenue for the six months ending November 30, 2020 came in at $8,688,758.


  • Revenue for the quarter ending November 30, 2020 of $4,907,889 represented a 61% increase over the same quarter in 2019, and a 29.8% increase over the first fiscal Q in 2021.


  • Assets reported on its most recent quarter came in at $14,399,741.


  • Shares Outstanding: $126,571,416


  • Market Cap: $29,478,283


CLSH may not be at these levels much longer.



CLS Holdings, Inc. (OTCQB: CLSH) anticipates a continued rise in market penetration and growth throughout the rest of 2021, and with an array of new products launching in February and growth of the brand's new toll processing division, Trichome Harvest Company, CLS Holdings expects to see continued advancements in the coming months.



With many new operational developments at City Trees, including the development of a new division and rollout of new products, and increased sales at Oasis Cannabis, the Company continued to make strides in expanding its offerings and achieved its highest January revenue to date.


President and COO Andrew Glashow stated "We started turning a corner as a community in the New Year.  We focused on providing accessible pricing and an increasingly diverse menu of products at both City Trees and Oasis, and people continued to respond. We leaned into what we're good at - catering to locals, providing the best service, and providing some of the best extraction products on the market through our extraction facility."


The company also just announced that City Trees, the Company's manufacturing subsidiary is now offering 5 new distillate blends that are available in disposable vape pens, cartridges, and refill oil applicators.   


City Trees currently has over 70% market penetration and the brand is poised to continue growing market share and strengthen its position as Nevada's premier extract producer with the release of these new products.




This could be the biggest play we see in the cannabis space this year.


Other Companies in the news and featured on


Innerscope Hearing Technologies

Shares of stop sign company Innerscope Hearing Technologies, Inc. (OTC: INND), with no news or updates for at least six months on awoke from an all but dead sleep about one month ago to the day, trading at .0002 per share.  Over the past 30 days, the stock shot up almost 30,000% to .07 per share.  With no new information entering the market, that topping tail from yesterday could be a sign of things to come.   


Have a look at CLS Holdings, Inc. (OTCQB: CLSH).  They just came out with record numbers and could be well in its way to much higher valuations.

Innovation Pharmaceuticals, Inc.

When we first reported, we watched Innovation Pharmaceuticals, Inc. (OTCQB: IPIX) run 50% and engulf its previous resistance of .299.  Since, it has nearly doubled its valuation with what seems like almost record dollar volume. The big read bar from yesterday seems like the run could be over, at least until more information comes to light on 


Check out CLS Holdings, Inc. (OTCQB: CLSH) With 5 new products just released, this could be the catalyst that brings the stock to trade among the majors in the space. 


Sunshine Biopharma, Inc.

Sunshine Biopharma, Inc. (OTC Pink: SBFM) just engulfed its entire charg going back to May of 2019 with yesterday's big green bar.  News from February 4th is new to the market since our last report.  It would be perfectly healthy at these levels for the stock to see a 50% retracement prior to its next run.


Watch CLS Holdings, Inc. (OTCQB: CLSH).  The company anticipates a continued rise in market penetration and growth throughout the rest of 2021.


Enzolytics, Inc.


Shares of Enzolytics, Inc. (OTC Pink: ENZC) showed some promise last week after the announcement of the discovery of seven newly identified conserved target sites on the HIV virus.  A article on January 27th, seemed to be responsible for its 100% rise and subsequent 50% fall.  Since then the stock has rebounded and like sunshine, a 50% retracement could be considered healthy before its next run pending new information into the market.


In the meantime, Check out CLS Holdings, Inc. (OTCQB: CLSH).  This could be the biggest play in the cannabis space this year.



About CLS Holdings USA, Inc.


CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for "Cannabis Life Sciences," in recognition of the Company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.

Twitter: @CLSHoldingsUSA




Oasis Cannabis has operated a cannabis dispensary in the Las Vegas market since dispensaries first opened in Nevada in 2015 and has been recognized as one of the top marijuana retailers in the state. Its location within walking distance to the Las Vegas Strip and Downtown Las Vegas in combination with its delivery service to residents allows it to efficiently serve both locals and tourists in the Las Vegas area. In February 2019, it was named "Best Dispensary for Pot Pros" by Desert Companion Magazine. In August 2017, the company commenced wholesale offerings of cannabis in Nevada with the launch of its City Trees brand of cannabis concentrates and cannabis-infused products.




Founded in 2017, City Trees is a Nevada-based cannabis cultivation, production and distribution company. Offering a wide variety of products with consistent results, City Trees products are available in numerous dispensaries throughout the state of Nevada.




Total Addressable Market, or TAM, estimate is based on Nevada estimated sales data provided by BDS Analytics for December 2020. This estimate is based upon predicted results, is uncertain and involves known and unknown uncertainties and other factors that may cause actual results to be materially different from this estimate.

Figure reported as of January 28, 2021. Additional sales may increase this total for the remainder of January 2021.


Forward Looking Statements


This press release contains certain ''forward-looking information'' within the meaning of applicable Canadian securities legislation and ''forward-looking statements'' as that term is defined in the Private Securities Litigation Reform Act of 1995 (collectively, the ''forward-looking statements''). These statements relate to, among other things, the impact of the COVID-19 virus on our business, the results of our initiatives to retain our employees and strengthen our relationships with our customers and community during the pandemic, the effect of our initiatives to expand market share and achieve growth during and following the pandemic, results of operations and financial performance, anticipated future events, and the effectiveness of our business practices during the pandemic. The continued spread of COVID-19 could have, and in some cases already has had, an adverse impact on our business, operations and financial results, including through disruptions in our cultivation and processing activities, supply chains and sales channels, and retail dispensary operations as well as a deterioration of general economic conditions including a possible national or global recession. Due to the speed with which the COVID-19 situation is developing and the uncertainty of its magnitude, outcome and duration, it is not possible to estimate its impact on our business, operations or financial results; however, the impact could be material.  In some cases, you can identify forward looking statements by terminology such as ''may,'' ''might,'' ''will,'' ''should,'' ''intends,'' ''expects,'' ''plans,'' ''goals,'' ''projects,'' ''anticipates,'' ''believes,'' ''estimates,'' ''predicts,'' ''potential,'' or ''continue'' or the negative of these terms or other comparable terminology. These forward-looking statements are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements.  We cannot guarantee future results, levels of activity or performance. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These cautionary statements should be considered together with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, we do not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events or circumstances or to reflect the occurrence of unanticipated events. See CLS Holdings USA filings with the SEC and on its SEDAR profile at for additional details.


Contact Information:



Chairman and CEO

Jeff Binder


President and COO

Andrew Glashow




Investor Relations:


Source: CLS Holdings USA, Inc.




Through its evolution, found a niche in identifying companies that can be overlooked by the markets. We look for strong management, innovation, strategy, execution, and the overall potential for long- term growth. Aside from being a trusted resource for the Emerging Growth info-seekers, we are well known for discovering undervalued companies and bringing them to the attention of the investment community. Through our parent Company, we also have the ability to facilitate road shows to present your products and services to the most influential investment banks in the space.


All information and material contained herein as well as on the website is obtained from sources believed to be reliable and / or provided to by a third party, but not guaranteed to be accurate or all-inclusive. All material contained within this article, is for informational purposes only, and should not be construed as an offer or solicitation to buy or sell securities. The information includes certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks.  This report is not without bias. has motivation by means of either self-marketing or has been compensated by or for a company or companies discussed in this article. has been compensated fifteen thousand five hundred dollars in consideration for its work with CLS Holdings USA, Inc. can receive future compensation and has received additional past compensation, details about which can be found in our full disclosure, which can be found here, You can easily lose money investing in highly speculative small cap stocks like the ones mentioned within. Please consult an investment professional before investing in anything viewed within. When is long shares it will sell those shares. In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the website.






Company: -

Contact Email:


Innovation Pharmaceuticals (QB) (USOTC:IPIX)
Historical Stock Chart
From Dec 2021 to Jan 2022 Click Here for more Innovation Pharmaceuticals (QB) Charts.
Innovation Pharmaceuticals (QB) (USOTC:IPIX)
Historical Stock Chart
From Jan 2021 to Jan 2022 Click Here for more Innovation Pharmaceuticals (QB) Charts.